
Immune System Modelling and Simulation
212
(at a normal rate). Eventually, the immune system is weakened
in its ability to generate fresh diversity; hence it becomes more
vulnerable to new HIV strains and/or to other antigens.
5.3 Immunodominance in Cancer Immunotherapies
Anti-cancer vaccination is based on the existence of markers
expressed by tumour cells (the so-called tumour–associated
antigens or TAAs). In generic terms, cancer vaccination aims
at eliciting an immune response toward one or more TAAs
after injecting them together with highly immunogenic
epitopes (named the carrier), generally derived from another
organism. Cancer eradication ...